A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1

a Pediatric Brain Tumor Consortium study

  • Fangusaro, Jason
  • Onar-Thomas, Arzu
  • Poussaint, Tina Young
  • Wu, Shengjie
  • Ligon, Azra H
  • Lindeman, Neal
  • Campagne, Olivia
  • Banerjee, Anu
  • Gururangan, Sridharan
  • Kilburn, Lindsay B
  • Goldman, Stewart
  • Qaddoumi, Ibrahim
  • Baxter, Patricia
  • Vezina, Gilbert
  • Bregman, Corey
  • Patay, Zoltan
  • Jones, Jeremy Y
  • Stewart, Clinton F
  • Fisher, Michael J
  • Doyle, Laurence Austin
  • Smith, Malcolm
  • Dunkel, Ira J
  • Fouladi, Maryam
Neuro-Oncology 23(10):p 1777-1788, October 2021. | DOI: 10.1093/neuonc/noab047
Copyright © Copyright Oxford University Press 2021.
View full text|Download PDF